We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
85 hedge funds and large institutions have $668M invested in Crescent Biopharma in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more call options, than puts
Call options by funds: $1.53M | Put options by funds: $1.23M
24% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 25
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
1% more funds holding
Funds holding: 84 → 85 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 1.09% → 1.08% (-0.01%)
9% less capital invested
Capital invested by funds: $730M → $668M (-$62.6M)
Holders
85
Holders Change
+1
Holders Change %
+1.19%
% of All Funds
1.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
31
Reduced
25
Closed
10
Calls
$1.53M
Puts
$1.23M
Net Calls
+$304K
Net Calls Change
-$215K
Top Buyers
| 1 |
O
OppenheimerFunds
New York
|
+$22.1M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.88M |
| 3 |
Man Group
London,
United Kingdom
|
+$5.37M |
| 4 |
JG
Jefferies Group
New York
|
+$2.58M |
| 5 |
Axa
Paris,
France
|
+$1.71M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$9.12M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$4.7M |
| 3 |
AG
Artal Group
Luxembourg
|
-$4.03M |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.55M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.26M |
